MRK BUE Week ended 24 Jul 2026

Weekly Investor Report

Merck & Co., Inc. · Healthcare · Drug Manufacturers - General

Open interactive chart View report data
Latest close 41,860 ARS
4.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 18.2% above the Trend Line and sits at 98.9% of its 52-week range. The latest completed week returned 4.2%, after a 5.7% four-week move. The latest news-sentiment score is 52/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.

Setup score 70 out of 100
Latest Close 41,860 ARS 24 Jul 2026
1W Return 4.2% latest completed week
4W Return 5.7% short-term follow-through
12W Return 27.9% quarterly tape
Trend Breadth 90.4% 47 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • The trend backdrop is active with a 47-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 4.2% Latest completed week; four-week move 5.7%. Indicator stack 95/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 52/100 32 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 18.2% above the Trend Line and sits at 98.9% of its 52-week range. The latest completed week returned 4.2%, after a 5.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6612-week average 0.62

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.66Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 5.7% over four weeks, 27.9% over 12 weeks, and 91.1% over one year. The current trend has remained active for 47 consecutive weeks.

Performance by holding period

1W4.2%
4W5.7%
12W27.9%
26W28.0%
52W91.1%
Active trend streak47 weeks
Active weeks in one year47
Trend breadth90.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.86Latest activity-pressure read.
Pressure change645.1%Four-week change in activity pressure.
Leadership9.38Latest relative-leadership reading.
RS change-10.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 32 relevant articles.

8 positive · 21 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.6%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+14.8%Week of 26 Jun.
Worst week-5.7%Week of 6 Mar.
Latest week+4.2%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains7
Flat weeks0
Modest losses13
Sharp losses1
Recent vol5.3%13-week weekly-return volatility.
Base vol5.1%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew5.1% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape71/100

Trend, activity pressure, participation, and risk combine to a 71/100 tape read.

 Indicator analysis63/100

Latest 12-week confirmation: trend 12/12, activity pressure 4/12, relative leadership 9/12.

Activity pressure 0.66; 2 reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment52/100

Weighted news tone is neutral across 32 relevant articles.

Empire Financial Management Company LLC Sells 7,623 Shares of Merck & Co., Inc. $MRK Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202641,860 ARS4.2%35,417 ARS26,500 ARS0.869.385.3KOn
17 Jul 202640,160 ARS3.7%35,094 ARS26,306 ARS0.928.2113.3KOn
10 Jul 202638,720 ARS-3.1%34,807 ARS26,124 ARS0.462.214.3KOn
3 Jul 202639,960 ARS0.9%34,523 ARS25,950 ARS0.218.4613.7KOn
26 Jun 202639,600 ARS14.8%34,200 ARS25,767 ARS-0.1610.5322.4KOn
19 Jun 202634,480 ARS-2.4%33,939 ARS25,588 ARS-0.56-8.1571On
12 Jun 202635,340 ARS-2.4%33,779 ARS25,444 ARS-0.35-7.39223On
5 Jun 202636,225 ARS3.3%33,535 ARS25,288 ARS-0.523.435.8KOn
29 May 202635,080 ARS-3.5%33,174 ARS25,127 ARS-0.68-1.9414.6KOn
22 May 202636,360 ARS10.0%32,868 ARS24,974 ARS-0.8813.6515.8KOn
15 May 202633,040 ARS-0.1%32,569 ARS24,813 ARS-1.119.505.8KOn
8 May 202633,060 ARS1.0%32,342 ARS24,674 ARS-0.957.9910.7KOn
1 May 202632,720 ARS-2.2%32,097 ARS24,532 ARS-0.835.137.4KOn
24 Apr 202633,460 ARS-3.6%31,912 ARS24,391 ARS-0.637.5612.4KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.